Schroder Investment Management Group Lowers Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Schroder Investment Management Group lowered its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 22.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,636,630 shares of the real estate investment trust’s stock after selling 747,015 shares during the period. Schroder Investment Management Group’s holdings in Healthpeak Properties were worth $52,680,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of DOC. State Street Corp bought a new position in Healthpeak Properties in the 3rd quarter valued at $1,093,576,000. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the third quarter valued at $403,898,000. Principal Financial Group Inc. grew its position in Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after buying an additional 17,314,572 shares in the last quarter. Norges Bank bought a new position in Healthpeak Properties in the 4th quarter worth about $166,804,000. Finally, JPMorgan Chase & Co. raised its holdings in shares of Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after acquiring an additional 4,056,931 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on DOC shares. Wedbush cut their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. StockNews.com raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday, March 22nd. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research report on Wednesday, January 15th. Wells Fargo & Company cut their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Finally, Scotiabank dropped their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.92.

Healthpeak Properties Trading Up 0.2 %

Shares of DOC stock opened at $20.23 on Tuesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The business has a 50-day moving average of $20.22 and a 200 day moving average of $21.08. The stock has a market capitalization of $14.15 billion, a PE ratio of 57.79, a P/E/G ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 1-year low of $17.80 and a 1-year high of $23.26.

Healthpeak Properties Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a $0.305 dividend. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 14th. This represents a $1.22 annualized dividend and a dividend yield of 6.03%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.